Challenges of lupus pregnancies

Rheumatology (United Kingdom)

Volumn 47, Issue , 2008, Pages iii9-iii12

  Doria, A ^a   Tincani, A ^b   Lockshin, M ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Congenital heart block; Pregnancy; Pregnancy outcomes; Systemic lupus erythematosus; Systemic lupus erythematosus activity; Th1 and Th2 cytokines

Indexed keywords

ADALIMUMAB; ANTIINFLAMMATORY AGENT; ANTIMALARIAL AGENT; AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; CYCLOSPORIN A; CYTOKINE; DEXAMETHASONE; DOUBLE STRANDED DNA ANTIBODY; ESTRADIOL; ETANERCEPT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 6; LA ANTIBODY; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PROGESTERONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; RO ANTIBODY; TACROLIMUS; UNINDEXED DRUG; BIOLOGICAL FACTOR; GLUCOCORTICOID;

ARTICLE; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG SAFETY; ECLAMPSIA; FETOPLACENTAL UNIT; HELLP SYNDROME; HIGH RISK PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; LUPUS ERYTHEMATOSUS NEPHRITIS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL; ACUTE DISEASE; FEMALE; REVIEW;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIMALARIALS; BIOLOGICAL FACTORS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTERS;

EID: 68349149742     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken151     Document Type: Article

References (33)

1. Doria A, Iaccarino L, Sarzi-Puttini P et al. Estrogens in pregnancy and systemic lupus erythematosus. Ann N Y Acad Sci 2006;1069:247-56.
2. Doria A, Iaccarino L, Arienti S et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 2006;22:234-41.
3. Mintz G, Nitz J, Gutierrez G et al. Prospective study of pregnancy in systemic lupus erythematosus: results of a multi-disciplinary approach. J Rheumatol 1986;13:732-9.
4. Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus pregnancy: casecontrol prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984;77:893-8.
5. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum 1993;36:1392-7.
6. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy: the Hopkins lupus pregnancy center experience. Arthritis Rheum 1991;34:1538-45.
7. Ruitz-Irastorza G, Lima F, Alves J et al. Increased rate of lupus flare during pregnancy and the puerperium. Br J Rheumatol 1996;35:133-8.
8. Wong KL, Chan FY, Lee XP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 1991;151:269-73.
9. Tandon A, Ibanez D, Gladman DD, Urowitz MB. The effect of pregnancy on lupus nephritis. Arthritis Rheum 2004;50:3941-6.
10. Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus 2005;14:89-94.
11. Soubassi L, Haidopoulos D, Sindos M et al. Pregnancy outcome in women with preexisting lupus nephritis. J Obs Gynaecol 2004;24:630-4.
12. Petri M. The Hopkins lupus pregnancy center: ten key issues in management. Rheum Dis N Am 2007;33:227-35.
13. Doria A, Cutolo M, Ghirardello A et al. Steroid hormones and disease activity during pregnancy in systemic lupus eythematosus. Arthritis Rheum 2002;47:202-9.
14. Buyon JP, Kalunian KC, Ramsey-Goldman R et al. Assessing disease activity in SLE patients during pregnancy. Lupus 1999;8:677-84.
15. Ruiz-Irastorza G, Khamashta MA, Gordon C et al. Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. Arthritis Rheum 2004;51:78-82.
16. Tincani A, Bompane D, Danieli E, Doria A. Pregnancy, lupus and antiphosphpolipid syndrome (Huges syndrome). Lupus 2006;15:156-60.
17. Doria A, Ghirardello A, Iaccarino L et al. Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum 2004;51:989-95.
18. Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus 2004;13:688-9.
19. Carmona F, Font J, Moga I et al. Class III-IV proliferative lupus nephiritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 2005;53:182-8.
20. Brucato A. Prevention of congenital heart block in children of SSA-positive mothers. Rheumatology 2008;47(Suppl 3):iii35-8.
21. Di Simone N, Raschi E, Testoni C et al. Pathogenic role of anti-2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of 2-glycoprotein I binding to trophoblast cells and functional effects of anti-2-glycoprotein I antibodies in vitro. Ann Rheum Dis 2005;64:462-7.
22. Tincani A, Faden D, Biasini-Rebaioli C et al. Pregnancy in SLE (2): is it possible to predict gestational outcome? (abstract). Athritis Rheum 2002;812:S322.
23. Asherson RA, Galarza-Maldonado C, Sanin-Blair J. The HELLP syndrome, antiphospholipid antibodies, and syndromes. Clin Rheumatol 2008;27:1-4.
24. Erkan D, Tincani A, Meroni P, Lockshin M. Practice questions/answers about antiphospholipid syndrome pregnancy. Arthritis Rheum 2007;56:S557.
25. Ross G, Sammaritano L, Nass R, Lockshin M. Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003;157:397-402.
26. Tincani A, Danieli E, Nuzzo M et al. Impact of in utero environment on the offspring of lupus patients. Lupus 2006;15:801-7.
27. Østensen M, Khamashta M, Lockshin M et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209.
28. Østensen M, Lockshin M, Doria A et al. Update on safety during pregnancy of biological agents and some immunosuppressive antirheumatic drugs. Rheumatology 2008;47(Suppl 3):iii28-31.
29. Clowse MEB, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 2006;54:3640-7.
30. Hyrich KL, Symmons DP, Watson KD, Silman AJ. British Society for Rheumatology Biologics Register. Pregnancy outcome in women who were exposed to anti-tumor necrosis factor agents: results from a national population register. Arthritis Rheum 2006;54:2701-2.
31. Salmon JE, Alpert D. Are we coming to terms with tumor necrosis factor inhibition in pregnancy? Arthritis Rheum 2006;54:2353-5.
32. Carter JD, Ladhani A, Ricca L, Valeriano J, Vasey FB. A safety assessment of TNF antagonists during pregnancy: a review of the FDA Database. Arthritis Rheum 2007;56:S667.
33. Salmon JE, Girardi G, Lockshin MD. The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Nat Clin Pract Rheumatol 2007;3:140-7.